Anti thyroid drugs in first trimester may not be safe

836 Views

eMediNexus 28 January 2018

Anti thyroid drugs exposure during the first trimester is associated with significantly increased risk for congenital malformations, particularly for pregnancies in which women received prescriptions for MMI [methimazole] or both ATDs" (MMI or propylthiouracil [PTU]) as per an online study in Annals of Internal Medicine.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.